Sherri Fay

The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial

Kenneth Rockwood, Sherri Fay, Mary Gorman et al. · BMC Neurology · 2007 · 112 citations · Full text

The ADAS‐cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease

Kenneth Rockwood, Sherri Fay, Mary Gorman · International Journal of Geriatric Psychiatry · 2009 · 62 citations

Effect of galantamine on verbal repetition in AD

Kenneth Rockwood, Sherri Fay, Pamela Jarrett et al. · Neurology · 2007 · 54 citations

The Pictorial Fit-Frail Scale: Developing a Visual Scale to Assess Frailty

Olga Theou, Melissa K. Andrew, Sally Suriani Ahip et al. · Canadian Geriatrics Journal · 2019 · 43 citations · Full text

Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial

Cheryl Cook, Sherri Fay, Kenneth Rockwood · International Psychogeriatrics · 2008 · 42 citations · Full text